View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200 / Nab-Paclitaxel 100 / Carboplatin 5, Non-Small Cell Lung Cancer
Protocol-ID: 2648 V1.0 (Mini), TISL200/NPAC100/CRBP5, NSCLCIndication(s)
- Lung Carcinoma, Non-Small Cell (Squamous Cell Carcinoma); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.06.2024